Evaluation of treatment options of central serous chorioretinopathy
Not Applicable
- Conditions
- Central Serous Chorioretinoathy.Central Serous Chorioretinopathy
- Registration Number
- IRCT2017041533448N1
- Lead Sponsor
- Vice chancellor for research, Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with visual loss (2 lines Snellen chart or more) and in scan (the thickness of the central part of the macula greater than 250 microns) diagnosis of central serous chorioretinopathy they laid is.
Exclusion criteria: Patient with visual loss with pathological retinal diseases other than Central serous retinopathy and diabetic retinopathy and hypertensive retinopathy and retinal dystrophies and patients who do not have the desire to enter the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity. Timepoint: Before start the study and 2 months and 4 months after intervention. Method of measurement: Snellen acuity chart.
- Secondary Outcome Measures
Name Time Method Central Maclar Thickness. Timepoint: Before start the study and 2 months and 4 months after intervention. Method of measurement: Optical Coherence Tomography.